vs
eXp World Holdings, Inc.（EXPI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
eXp World Holdings, Inc.的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -1.1%，领先35.5%），eXp World Holdings, Inc.同比增速更快（8.5% vs 4.8%），过去两年eXp World Holdings, Inc.的营收复合增速更高（12.4% vs 4.6%）
eXp World Holdings是全球云原生房地产服务提供商，运营eXp Realty经纪网络，依托沉浸式3D虚拟园区支持代理人协作与日常运营，业务覆盖全球20余个国家的住宅及商业地产市场，同时提供按揭贷款、产权保险、从业者职业培训等配套服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
EXPI vs RPRX — 直观对比
营收规模更大
EXPI
是对方的1.9倍
$622.0M
营收增速更快
EXPI
高出3.8%
4.8%
净利率更高
RPRX
高出35.5%
-1.1%
两年增速更快
EXPI
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $-12.9M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -1.1% | 62.4% |
| 净利率 | -1.1% | 34.4% |
| 营收同比 | 8.5% | 4.8% |
| 净利润同比 | -35.7% | 2.9% |
| 每股收益（稀释后） | $-0.08 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPIRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.3B | $609.3M | ||
| Q2 25 | $1.3B | $578.7M | ||
| Q1 25 | $954.9M | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.3B | $537.3M | ||
| Q1 24 | $943.1M | $568.0M |
净利润EXPIRPRX
| Q4 25 | $-12.9M | $214.2M | ||
| Q3 25 | $3.5M | $288.2M | ||
| Q2 25 | $-2.3M | $30.2M | ||
| Q1 25 | $-11.0M | $238.3M | ||
| Q4 24 | $-9.5M | $208.2M | ||
| Q3 24 | $-8.5M | $544.0M | ||
| Q2 24 | $12.4M | $102.0M | ||
| Q1 24 | $-15.6M | $4.8M |
毛利率EXPIRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.9% | — | ||
| Q1 24 | — | — |
营业利润率EXPIRPRX
| Q4 25 | -1.1% | 62.4% | ||
| Q3 25 | 0.3% | 70.1% | ||
| Q2 25 | -0.2% | 36.3% | ||
| Q1 25 | -1.1% | 94.0% | ||
| Q4 24 | -1.0% | 60.9% | ||
| Q3 24 | -0.7% | — | ||
| Q2 24 | 1.4% | 50.2% | ||
| Q1 24 | -1.9% | -13.0% |
净利率EXPIRPRX
| Q4 25 | -1.1% | 34.4% | ||
| Q3 25 | 0.3% | 47.3% | ||
| Q2 25 | -0.2% | 5.2% | ||
| Q1 25 | -1.2% | 41.9% | ||
| Q4 24 | -0.9% | 35.1% | ||
| Q3 24 | -0.7% | 96.3% | ||
| Q2 24 | 1.0% | 19.0% | ||
| Q1 24 | -1.7% | 0.8% |
每股收益（稀释后）EXPIRPRX
| Q4 25 | $-0.08 | $0.49 | ||
| Q3 25 | $0.02 | $0.67 | ||
| Q2 25 | $-0.01 | $0.07 | ||
| Q1 25 | $-0.07 | $0.55 | ||
| Q4 24 | $-0.06 | $0.46 | ||
| Q3 24 | $-0.06 | $1.21 | ||
| Q2 24 | $0.08 | $0.23 | ||
| Q1 24 | $-0.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $242.8M | $9.7B |
| 总资产 | $442.5M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资EXPIRPRX
| Q4 25 | $124.2M | $618.7M | ||
| Q3 25 | $112.8M | $938.9M | ||
| Q2 25 | $94.6M | $631.9M | ||
| Q1 25 | $115.7M | $1.1B | ||
| Q4 24 | $113.6M | $929.0M | ||
| Q3 24 | $130.4M | $950.1M | ||
| Q2 24 | $108.4M | $1.8B | ||
| Q1 24 | $109.2M | $843.0M |
总债务EXPIRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益EXPIRPRX
| Q4 25 | $242.8M | $9.7B | ||
| Q3 25 | $235.3M | $9.6B | ||
| Q2 25 | $218.4M | $9.5B | ||
| Q1 25 | $212.0M | $9.8B | ||
| Q4 24 | $204.9M | $10.3B | ||
| Q3 24 | $211.1M | $10.3B | ||
| Q2 24 | $220.3M | $9.8B | ||
| Q1 24 | $222.4M | $9.9B |
总资产EXPIRPRX
| Q4 25 | $442.5M | $19.6B | ||
| Q3 25 | $458.7M | $19.3B | ||
| Q2 25 | $481.2M | $18.3B | ||
| Q1 25 | $435.8M | $17.6B | ||
| Q4 24 | $390.7M | $18.2B | ||
| Q3 24 | $432.6M | $18.0B | ||
| Q2 24 | $457.4M | $17.7B | ||
| Q1 24 | $426.7M | $16.1B |
负债/权益比EXPIRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $11.9M | — |
| 自由现金流率自由现金流/营收 | 1.0% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $109.0M | — |
8季度趋势，按日历期对齐
经营现金流EXPIRPRX
| Q4 25 | $13.8M | $827.1M | ||
| Q3 25 | $28.9M | $702.6M | ||
| Q2 25 | $36.1M | $364.0M | ||
| Q1 25 | $39.8M | $596.1M | ||
| Q4 24 | $13.7M | $742.5M | ||
| Q3 24 | $46.0M | $703.6M | ||
| Q2 24 | $71.1M | $658.2M | ||
| Q1 24 | $60.7M | $664.6M |
自由现金流EXPIRPRX
| Q4 25 | $11.9M | — | ||
| Q3 25 | $26.6M | — | ||
| Q2 25 | $33.3M | — | ||
| Q1 25 | $37.3M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $44.4M | — | ||
| Q2 24 | $69.7M | — | ||
| Q1 24 | $59.3M | — |
自由现金流率EXPIRPRX
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 6.3% | — |
资本支出强度EXPIRPRX
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率EXPIRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 8.26× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 5.75× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXPI
| North American Realty | $1.1B | 96% |
| International Realty | $42.2M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
